Clinical trial

A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes

NCT01121276

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-04-01

PhasePHASE1

Study timeline

Study start (unknown)2010-04-01Date precision: month

Registry last updated2017-01-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitus, Type 1unresolved

Diabetes Mellitus, Type 2unresolved

Interventions

Faster-acting insulin aspartDRUG

insulin aspartDRUG

Faster-acting insulin aspartDRUG

Faster-acting insulin aspartDRUG

Faster-acting insulin aspartDRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

Chula VistaCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01121276 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.